VolitionRx Limited (NYSE AMERICAN: VNRX), taking high notes in the pre-market after the introduction of its first product
Hasnain Khan
December 2, 2020
VolitionRx Limited (NYSE AMERICAN: VNRX), flying in the pre-market after the announcement of the launch of its first product, the Nu.Q Vet Cancer Screening Test.